Kromek Group
Ticker: KMK Exchange: AIM www.kromek.com

Kromek listed on the AIM market in October, 2013 and is a UK company pioneering digital colour imaging for x-rays using cadmium zinc telluride crystals.

£5m biological threat-detection contract award

Kromek Group has announced the award of a three-year UK Government department biological threat-detection programme contract worth £4.9m. Work on the contract is scheduled to commence in December 2022; the three-year term includes an option for extended maintenance-related services.

This is a significant contract and a clear ratification of the development work undertaken by Kromek, focused on the detection of biohazards which include the recent COVID-19 pandemic, but also extend to the development of systems capable of identifying and geo-locating other biological threats. In an environment currently absorbed by a variety of economic and geopolitical risks, the threat represented by natural or man-made biological agents has not diminished.

On the 10th November, Kromek added that it expects revenue growth of “approximately 45% for the six months to 31 October 2022. The latest, £5m, biohazard detection contract, adds to this momentum. Our FY23 outlook remains unchanged at £18.0m revenue, +49%YoY (E), EBITDA (adj.) of £0.3m, and a reduced EBIT loss of (£4.3m) vs FY22: (£5.5m). We also retain our Fair Value at 26p/share.

 

 
Download as a PDF file
26810392321 - kromek-group
Return to Kromek Group

Register to be first

Get research on the companies that interest you straight to your inbox

Register For Updates